Barbara Fischer, PsyD, and Carey Gleason, PhD, MS, recently published research findings about a blood biomarker and a method of testing cognitive processes that could hold promise for identifying middle-aged Black people who are at risk for later developing Alzheimer’s disease.
Welcome
The Wisconsin Alzheimer’s Disease Research Center supports researchers in their pursuit of answers that will lead to improved diagnosis and care for patients while, at the same time, focusing on the program’s long-term goal — finding a way to prevent and effectively treat Alzheimer’s disease.
Recent News
Image
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy.
Image
Cynthia Carlsson, MD, MS, is leading a research team at UW–Madison investigating a drug that could one day prevent Alzheimer’s disease.
Image
The annual awards acknowledge and honor women of color among UW–Madison’s faculty, staff, students and in the greater Madison community whose advocacy, activism, or scholarship has fostered social justice and organizational change.
Image
Kimberly Mueller, PhD, CCC-SLP, was recently appointed to associate professor with tenure in the Department of Communication Sciences and Disorders at the University of Wisconsin–Madison.
Image
Brain assessments of World War II, Korean and Vietnam War-era veterans uncover disease biomarkers.
No front page content has been created yet.
Follow the User Guide to start building your site.
Follow the User Guide to start building your site.
